BSE Live
Oct 13, 16:01Prev. Close
83.47
Open Price
83.49
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 13, 15:54Prev. Close
83.10
Open Price
83.00
Bid Price (Qty.)
82.10 (1015)
Offer Price (Qty.)
0.00 (0)
Cash Flow of Bal Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 5.14 | 9.05 | 4.75 | 9.18 | 4.10 | |
Net CashFlow From Operating Activities | 20.32 | 22.81 | -1.84 | 27.71 | 21.78 | |
Net Cash Used In Investing Activities | -14.92 | -18.89 | -22.18 | -9.48 | -4.98 | |
Net Cash Used From Financing Activities | -7.84 | -1.21 | 24.40 | -18.13 | -16.63 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | -2.44 | 2.71 | 0.37 | 0.09 | 0.16 | |
Cash And Cash Equivalents Begin of Year | 4.20 | 1.49 | 1.11 | 1.02 | 0.86 | |
Cash And Cash Equivalents End Of Year | 1.75 | 4.20 | 1.49 | 1.11 | 1.02 |
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
03.06.2025
Bal Pharma Consolidated March 2025 Net Sales at Rs 81.88 crore, down 13.47% Y-o-Y
04.03.2025
Bal Pharma Consolidated December 2024 Net Sales at Rs 73.15 crore, down 10.42% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
03.06.2025
Bal Pharma Consolidated March 2025 Net Sales at Rs 81.88 crore, down 13.47% Y-o-Y
04.03.2025
Bal Pharma Consolidated December 2024 Net Sales at Rs 73.15 crore, down 10.42% Y-o-Y